Larinate Tablet is a fixed-dose combination of three antimalarial agents—Artesunate, Sulfadoxine, and Pyrimethamine—designed to effectively treat uncomplicated malaria caused by Plasmodium falciparum. This combination therapy is recommended by the World Health Organization (WHO) as a first-line treatment for malaria in regions with high transmission rates. For more details on malaria treatment guidelines, you can refer to resources like Mayo Clinic and WebMD.

Key Benefits & Uses

• Effective Malaria Treatment: Combines three potent antimalarial drugs to target the parasite at different stages of its lifecycle. Learn more on Drugs.com.

• Single-Dose Regimen: Simplifies treatment adherence with a fixed-dose combination.

• Broad-Spectrum Action: Targets Plasmodium falciparum, the most deadly malaria parasite (PubMed).

• Trusted & Safe: Supported by health authorities like the FDA and Healthline.

How to Use

• Take the tablet as prescribed by your healthcare provider.

• Swallow whole with food to improve absorption.

• Do not chew, crush, or break the tablet.
  For safety guidance, visit Mayo Clinic or Drugs.com.

Important Safety Information

• Consult your doctor before use if you are pregnant or breastfeeding (WebMD).

• Avoid alcohol during treatment.

• Inform your doctor if you have liver, kidney, or heart conditions.

• Always follow the guidelines recommended by the FDA and WHO.

Common Side Effects

• Nausea, vomiting, diarrhea, headache, dizziness, fatigue, skin rash, mouth sores.

• Most side effects are mild and temporary. If symptoms persist, consult a healthcare professional.
  More information on side effects is available on Healthline and PubMed.

Why Choose Larinate Tablet?

• Clinically proven efficacy in treating Plasmodium falciparum malaria (PubMed).

• WHO-recommended and widely recognized as an essential medicine (WHO).

• Fixed-dose combination simplifies treatment and ensures better compliance.
  Learn more about antimalarial medications at Mayo Clinic and Drugs.com.